Error loading player: No playable sources found
3545
Liver & Biliary (LB) Section Distinguished Abstract Plenary
Date
May 4, 2025
This product is not available for individual purchase, but it is available as part of the following products:
Don't miss the opportunity to access the latest research and discoveries in the field of digestive diseases. DDW On Demand is a valuable and convenient way to enhance your knowledge and skills in digestive disease care…
Society: AGA
This session features the top abstracts submitted and reviewed by the Liver & Biliary (LB) section, showcasing cutting-edge research and advancements in liver and biliary diseases. Attendees will gain insights into genetic and clinical predictors of mortality in steatotic liver disease, the impact of nutritional therapy on frailty status in cirrhotic patients, and the efficacy and safety of novel treatments for primary biliary cholangitis and hepatocellular carcinoma. Additionally, the session will explore the use of AI models for predicting advanced liver fibrosis and cardiovascular mortality in MASLD.
This session features the top abstracts submitted and reviewed by the Liver & Biliary (LB) section, showcasing cutting-edge research and advancements in liver and biliary diseases. Attendees will gain insights into genetic and clinical predictors of mortality in steatotic liver disease, the impact of nutritional therapy on frailty status in cirrhotic patients, and the efficacy and safety of novel treatments for primary biliary cholangitis and hepatocellular carcinoma. Additionally, the session will explore the use of AI models for predicting advanced liver fibrosis and cardiovascular mortality in MASLD.
Moderators
University of Alabama at Birmingham
Medical University of South Carolina, Dept. of Internal Medicine
Related Products
Annual Business Meeting
SOCIETY: SSAT
Academic Debate: Advanced ALD and Alcohol-Associated Hepatitis Finding the Best Path for Your Patient
This session includes audience response. Visit gastro.cnf.io during the scheduled session time to participate. This session will be a debate regarding the PROS and CONS of steroids and clinical trials for the treatment of alcohol-associated hepatitis…
Diagnosis and Management of Early Alcohol-Associated Liver Disease
Alcohol-associated liver disease (ALD) and alcohol use disorder (AUD) are often concomitant diseases. Compared to other liver disease, ALD often presents at an advanced stage and after presentation progresses faster to decompensation with a reduced patient survival…
Endoscopy for Portal Hypertension, Complications of Cirrhosis, and GI Bleeding
Delve into the latest advancements in managing portal hypertension, complications of cirrhosis, and GI bleeding through endoscopic interventions…
